U.S. wholesalers bid to distribute Covid-19 shots – STAT
Novartis is in talks to produce Covid-19 vaccines or therapies made by other companies as the industry mobilizes amid fights over access.
Related Articles
Colombia issues a compulsory license for an HIV medicine and ‘plants a flag for global health equity’
“Colombia is planting a flag for global health equity,” said Peter Maybarduk, who heads the access to medicines campaign at Public Citizen.
Pharmalittle: We’re reading about a Senate probe into Novo pricing, a new UTI antibiotic, and more
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
Colombia issues a compulsory license for an HIV medicine and ‘plants a flag for global health equity’
“Colombia is planting a flag for global health equity,” said Peter Maybarduk, who heads the access to medicines campaign at Public Citizen.
Biosimilars haven’t always yielded lower out-of-pocket costs for patients, study finds
The authors of a new study argue the heralded arrival of biosimilars failed to fully deliver on their promise.
Colombia issues a compulsory license for an HIV medicine and ‘plants a flag for global health equity’
“Colombia is planting a flag for global health equity,” said Peter Maybarduk, who heads the access to medicines campaign at Public Citizen.
Pharmalittle: We’re reading about GLP-1 spending, biosimilar patient costs, and more
Spending on GLP-1 drugs like Ozempic and Wegovy ballooned last year and they’re set to cost the U.S. health care system and the federal government…
Pharmalittle: We’re reading about Lilly buying a plant, a Pfizer antibiotic, and more
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
Pharmalittle: We’re reading about an OptumRx contract, 340B dispute resolution, and more
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth’s OptumRx unit will not be renewed after they expire in June.
Up and down the ladder: The latest comings and goings
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
Pharmalittle: We’re reading about plans for generic Wegovy, cough syrup warnings, and more
Biocon is developing a generic version of Novo Nordisk’s Wegovy and is prepared to conduct a clinical trial next year if needed.